Versant Venture Capital VI, L.P. — SEC Form 4 filings
SEC reporting owner CIK 1687880. 17 Form 4 filings on record with FilingPulse; latest filed 2025-10-02.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-03-25 to 2025-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 52 legs across 15 filings — 9,340,372 shares, $87,832,853 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 350,000 shares @ $29.00 ($10,150,000) in LENZ Therapeutics, Inc., filed 2025-06-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. (LENZ) | 10% owner | 9 | — | 34 legs · 1,885,262 sh · $66,603,139 | 1 |
| Monte Rosa Therapeutics, Inc. (GLUE) | 10% owner | 3 | — | 7 legs · 1,857,674 sh · $12,291,035 | 10 |
| LAVA Therapeutics NV (LVTX) | 10% owner | 2 | — | 8 legs · 4,587,837 sh · $6,571,090 | — |
| Black Diamond Therapeutics, Inc. (BDTX) | 10% owner | 1 | — | 1 leg · 221,600 sh · $1,400,556 | — |
| Tempest Therapeutics, Inc. (TPST) | 10% owner | 1 | — | 2 legs · 787,999 sh · $967,033 | — |
| Contineum Therapeutics, Inc. (CTNM) | 10% owner | 1 | — | — | 21 |
Form 4 filings — Versant Venture Capital VI, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-02 | 4 | LENZ Therapeutics, Inc. (LENZ) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP, L.P., Versant Ventures VII GP-GP, LLC | Sale (S): 49,701 @ $45.35 · Sale (S): 34,405 @ $45.35 · Sale (S): 83,066 @ $46.41 · Sale (S): 57,502 @ $46.41 · Sale (S): 177 @ $47.01 · Sale (S): 123 @ $47.01 | EDGAR |
| 2025-09-23 | 4 | LAVA Therapeutics NV (LVTX) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC | Sale (S): 2,370,533 @ $1.40 · Sale (S): 532,870 @ $1.40 | EDGAR |
| 2025-09-22 | 4 | LENZ Therapeutics, Inc. (LENZ) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP, L.P., Versant Ventures VII GP-GP, LLC | Sale (S): 49,479 @ $41.59 · Sale (S): 24,370 @ $41.59 · Sale (S): 40,907 @ $43.00 · Sale (S): 20,148 @ $43.00 · Sale (S): 268 @ $43.30 · Sale (S): 132 @ $43.30 | EDGAR |
| 2025-09-18 | 4 | LAVA Therapeutics NV (LVTX) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC | Sale (S): 307,707 @ $1.53 · Sale (S): 192,293 @ $1.53 · Sale (S): 362,806 @ $1.49 · Sale (S): 226,726 @ $1.49 · Sale (S): 366,111 @ $1.44 · Sale (S): 228,791 @ $1.44 | EDGAR |
| 2025-08-26 | 4 | LENZ Therapeutics, Inc. (LENZ) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP, L.P., Versant Ventures VII GP-GP, LLC | Sale (S): 20,493 @ $40.03 · Sale (S): 10,076 @ $40.03 · Sale (S): 5,668 @ $40.59 · Sale (S): 2,809 @ $40.59 · Sale (S): 50,270 @ $39.53 · Sale (S): 24,760 @ $39.53 · +6 more | EDGAR |
| 2025-08-19 | 4 | LENZ Therapeutics, Inc. (LENZ) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP, L.P., Versant Ventures VII GP-GP, LLC | Sale (S): 145,051 @ $39.50 · Sale (S): 69,949 @ $39.50 · Sale (S): 30,628 @ $38.56 · Sale (S): 15,085 @ $38.56 | EDGAR |
| 2025-07-14 | 4 | LENZ Therapeutics, Inc. (LENZ) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP, L.P., Versant Ventures VII GP-GP, LLC | Sale (S): 191,376 @ $34 | EDGAR |
| 2025-07-01 | 4 | LENZ Therapeutics, Inc. (LENZ) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP, L.P., Versant Ventures VII GP-GP, LLC | Sale (S): 200,000 @ $30.46 | EDGAR |
| 2025-06-20 | 4 | LENZ Therapeutics, Inc. (LENZ) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP, L.P., Versant Ventures VII GP-GP, LLC | Sale (S): 100,000 @ $29.95 · Sale (S): 100,877 @ $30.35 · Sale (S): 133,924 @ $30.25 | EDGAR |
| 2025-06-12 | 4 | LENZ Therapeutics, Inc. (LENZ) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP, L.P., Versant Ventures VII GP-GP, LLC | Sale (S): 350,000 @ $29 | EDGAR |
| 2024-10-30 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC | Sale (S): 89,990 @ $9.66 · Other (J): 1,019,867 @ $0 · Other (J): 20,397 @ $0 · Other (J): 20,397 @ $0 · Other (J): 17,595 @ $0 · Other (J): 17,595 @ $0 · +7 more | EDGAR |
| 2024-09-24 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC | Sale (S): 1,132,566 @ $6.53 | EDGAR |
| 2024-09-13 | 4 | Monte Rosa Therapeutics, Inc. (GLUE) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC | Sale (S): 541,897 @ $6 · Sale (S): 16,047 @ $6.00 · Sale (S): 9,269 @ $6.16 | EDGAR |
| 2024-08-30 | 4 | Black Diamond Therapeutics, Inc. (BDTX) jointly with Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P., Versant Vantage I, L.P. | Sale (S): 221,600 @ $6.32 | EDGAR |
| 2024-08-12 | 4 | Tempest Therapeutics, Inc. (TPST) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Ventures IV, LLC, Versant Venture Capital IV, L.P., Versant Side Fund IV, L.P. | Sale (S): 400,000 @ $1.35 · Sale (S): 387,999 @ $1.10 | EDGAR |
| 2024-04-11 | 4 | Contineum Therapeutics, Inc. (CTNM) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC, Versant Venture Capital IV, L.P., Versant Side Fund IV, L.P., Versant Ventures IV, LLC | Conversion (C): 391,785 · Conversion (C): 2,531 · Conversion (C): 148,312 · Conversion (C): 298,975 (derivative) · Conversion (C): 1,931 (derivative) · Conversion (C): 70,498 (derivative) · +15 more | EDGAR |
| 2024-03-25 | 4 | LENZ Therapeutics, Inc. (LENZ) jointly with Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP, L.P., Versant Ventures VII GP-GP, LLC | Other (J): 598,203 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1687880 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →